We live in a world invaded by plastic. Its role as a chemically stable, versatile and multi-purpose fostered its massive use, which has finally translated into our current situation of planetary pollution. Moreover, when plastic […]
The regulatory environment for live biotherapeutic products is still uncertain globally, of course, but one booming area is the manufacturing of these products as they move through their clinical development process. Adrien Nivoliez, CEO of Biose Industrie reflects on […]
It’s not stress that kills us; it is our reaction to it” are the famous words of the Hungarian physiologist Hans Selye. Indeed understanding how stress affects the body is an important endeavour in understanding […]
From the perspective of A. Murat Eren, PhD, the mouth is the perfect place to study microbial communities. “Not only is it the beginning of the GI tract, but it’s also a very special and […]
The balance of microbiota in the gut has a significant effect on general wellbeing, as well as clear associations with many diseases and a patient’s response to certain treatments. The role of the microbiota in […]
In recent years, the microbiota — the community of bacteria and other microorganisms that live on and in the human body — has captured the attention of scientists and the public, in part because it’s […]
The Regents of the University of California and Evolve BioSystems are pleased to announce that an Illinois federal judge has recently denied a motion by Abbott Laboratories to dismiss a patent infringement suit jointly filed […]
Every microbiome-focused company has its own approach for discovering drug candidates—but rarely is the mechanism of action for a live biotherapeutic product (LBP) known from the outset. Microbiome pharma company ImmunoBiome, however, uses a unique […]
The work of Leonardo Da Vinci is an invaluable heritage of the 15th century. From engineering to anatomy, the master paved the way for many scientific disciplines. But what else could the drawings of Da […]
Persephone Biosciences Inc., a biotechnology company that leverages real world data and artificial intelligence to design microbiome therapeutics and diagnostics to promote normal immune function and fight disease, today announced the initiation of the ARGONAUT […]
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) and MyBiotics Pharma Ltd. announced today they have entered into a research and development collaboration agreement to identify and optimize the selected microbiome repertoire associated with the response to Aramchol. […]